Insulin Pulse Characteristics and Insulin Action in Non-diabetic Humans.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
13 05 2021
Historique:
received: 28 10 2020
pubmed: 20 2 2021
medline: 3 11 2021
entrez: 19 2 2021
Statut: ppublish

Résumé

Pulsatile insulin secretion is impaired in diseases such as type 2 diabetes that are characterized by insulin resistance. This has led to the suggestion that changes in insulin pulsatility directly impair insulin signaling. We sought to examine the effects of pulse characteristics on insulin action in humans, hypothesizing that a decrease in pulse amplitude or frequency is associated with impaired hepatic insulin action. We studied 29 nondiabetic subjects on two occasions. On 1 occasion, hepatic and peripheral insulin action was measured using a euglycemic clamp. The deuterated water method was used to estimate the contribution of gluconeogenesis to endogenous glucose production. On a separate study day, we utilized nonparametric stochastic deconvolution of frequently sampled peripheral C-peptide concentrations during fasting to reconstruct portal insulin secretion. In addition to measuring basal and pulsatile insulin secretion, we used approximate entropy to measure orderliness and Fourier transform to measure the average, and the dispersion of, insulin pulse frequencies. In univariate analysis, basal insulin secretion (R2 = 0.16) and insulin pulse amplitude (R2 = 0.09) correlated weakly with insulin-induced suppression of gluconeogenesis. However, after adjustment for age, sex, and weight, these associations were no longer significant. The other pulse characteristics also did not correlate with the ability of insulin to suppress endogenous glucose production (and gluconeogenesis) or to stimulate glucose disappearance. Overall, our data demonstrate that insulin pulse characteristics, considered independently of other factors, do not correlate with measures of hepatic and peripheral insulin sensitivity in nondiabetic humans.

Identifiants

pubmed: 33606017
pii: 6145034
doi: 10.1210/clinem/dgab100
pmc: PMC8344841
doi:

Substances chimiques

Blood Glucose 0
C-Peptide 0
Insulin 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1702-1709

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK078646
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK116231
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000135
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E687-E694
pubmed: 30807214
J Clin Endocrinol Metab. 1997 Dec;82(12):4088-93
pubmed: 9398719
N Engl J Med. 1988 May 12;318(19):1225-30
pubmed: 3283553
J Clin Invest. 1995 Jan;95(1):172-8
pubmed: 7814612
Diabetes. 1990 Apr;39(4):501-7
pubmed: 2180760
Diabetologia. 2008 Mar;51(3):502-11
pubmed: 18080106
Clin Endocrinol (Oxf). 2012 Feb;76(2):212-9
pubmed: 21707690
Diabetes. 2008 Jan;57(1):50-5
pubmed: 17934142
Diabetes. 1983 Jul;32(7):617-21
pubmed: 6134649
J Hypertens. 2000 Jun;18(6):743-8
pubmed: 10872559
Metabolism. 2003 Aug;52(8):1050-5
pubmed: 12898472
Diabetes. 2013 Apr;62(4):1094-101
pubmed: 23250357
Diabetes. 2012 Sep;61(9):2269-79
pubmed: 22688333
Am J Physiol. 1997 Nov;273(5):E908-14
pubmed: 9374676
N Engl J Med. 1992 Sep 3;327(10):707-13
pubmed: 1495524
Diabetes. 2016 Apr;65(4):887-92
pubmed: 26822092
Endocrinology. 1986 Jan;118(1):312-9
pubmed: 3000741
Metabolism. 2012 Aug;61(8):1177-81
pubmed: 22386942
Diabetes. 2000 Feb;49(2):272-83
pubmed: 10868944
Am J Physiol. 1989 Aug;257(2 Pt 1):E241-6
pubmed: 2669517
Am J Physiol. 1956 Sep;187(1):15-24
pubmed: 13362583
Am J Physiol Endocrinol Metab. 2013 Apr 15;304(8):E819-25
pubmed: 23443923
Diabetes Obes Metab. 2018 Mar;20(3):549-555
pubmed: 28862812
Diabetes. 2006 Aug;55(8):2347-56
pubmed: 16873700
Diabetes. 1986 Aug;35(8):922-6
pubmed: 3525288
Am J Physiol. 1999 Aug;277(2):E283-90
pubmed: 10444424
Physiol Res. 2008;57 Suppl 1:S91-S98
pubmed: 18271688
Diabetologia. 2004 Jan;47(1):31-9
pubmed: 14666364
Diabetologia. 2017 Aug;60(8):1483-1490
pubmed: 28551698
Diabetes. 1986 Jul;35(7):776-84
pubmed: 3522319
J Clin Endocrinol Metab. 2005 Jan;90(1):493-500
pubmed: 15483086
Diabetes. 2002 Feb;51 Suppl 1:S245-54
pubmed: 11815487
Diabetes. 2005 Jun;54(6):1649-56
pubmed: 15919785
Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E401-6
pubmed: 18492770
J Clin Endocrinol Metab. 1988 Nov;67(5):1005-10
pubmed: 3053747
Diabetes. 1996 May;45(5):683-6
pubmed: 8621023
Diabetes. 2006 Apr;55(4):1051-6
pubmed: 16567528
JCI Insight. 2020 Apr 9;5(7):
pubmed: 32182220

Auteurs

Marcello C Laurenti (MC)

Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic, Rochester, MN, USA.

Chiara Dalla Man (C)

Department of Information Engineering, University of Padova, Padova, Italy.

Ron T Varghese (RT)

Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic, Rochester, MN, USA.

James C Andrews (JC)

Vascular and Interventional Radiology, Mayo Clinic, Rochester, MN, USA.

John G Jones (JG)

Center for Neurosciences, University of Coimbra, Coimbra, Portugal.

Cristina Barosa (C)

Center for Neurosciences, University of Coimbra, Coimbra, Portugal.

Robert A Rizza (RA)

Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic, Rochester, MN, USA.

Aleksey Matveyenko (A)

Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic, Rochester, MN, USA.
Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.

Giuseppe De Nicolao (G)

Department of Computer Engineering and Systems Science, University of Pavia, Pavia, Italy.

Kent R Bailey (KR)

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.

Claudio Cobelli (C)

Department of Information Engineering, University of Padova, Padova, Italy.

Adrian Vella (A)

Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH